Director, Medical Affairs - Rare Diseases

Das ist der Job

Provide scientific and medical leadership throughout pre-launch, launch and post-launch phases.

Darum lohnt es sich

We are seeking a Director, Medical Affairs, Rare Diseases - Europe to join our Medical Affairs team. Fluency in English and willingness to travel nationally and internationally approximately 30–50%.

Salary Range (annually) €125,250.00 - €208,750.00 Regeneron offers a competitive and comprehensive total rewards package which may include, depending on country and role: • annual bonuses or other incentive plans • equity awards • pension or retirement benefits • 401(k) company match • health and wellness programs • fitness centers • insurance benefits (e.g. medical, dental, vision, life and disability) • paid time off • family support benefits For additional information about Regeneron benefits in the U.S., please visit For other locations, additional information will be provided during the recruitment process.

Build our future together: At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. In this hybrid role, you will lead medical strategy and scientific engagement across investigational and approved therapies in rare diseases.

Working closely with Global Medical Affairs, Clinical Development, HEOR, Medical Operations, Publications and Statistics, you will drive evidence generation, build scientific partnerships and translate external insights into strategic recommendations supporting patient needs and medical excellence.

When & where: Munich (Hybrid) Discover your role: Lead medical strategies and tactical plans across assigned rare disease assets and therapeutic areas. Establish scientific partnerships with healthcare professionals, researchers, advocacy organisations, payers and other external stakeholders.

Drive evidence generation through Medical Affairs studies, data analysis, publications and scientific communication plans. Translate clinical and country insights into recommendations supporting medical strategy, patient access and value demonstration.

Manage complex priorities, budgets and timelines while maintaining scientific integrity and compliance. You bring a collaborative, patient-focused approach to scientific leadership and external engagement. This role requires: MD, DO, PharmD, PhD or an equivalent advanced scientific or clinical degree.

Minimum 8 years of Medical Affairs experience with increasing responsibility. Expertise in rare diseases and/or genetic medicine. Experience leading medical strategy, scientific communications and evidence generation. Strong understanding of drug development and lifecycle management.

Experience in rare genetic diseases, gene therapy, regenerative medicine or rare bone, muscle or cardiovascular disorders preferred. Product launch, clinical trial, publication or field Medical Affairs leadership experience preferred. Multi-country experience and additional languages preferred.

Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law.

Where required, we will provide reasonable accommodation to applicants with known disabilities or chronic illnesses during the recruitment process, unless such accommodation would impose undue hardship. Please be advised that at Regeneron, we believe we do our best work when we are together.

For that reason, many roles are required to be performed on‑site. As part of the recruitment process, certain background checks may be conducted in accordance with the laws of the country where the position is based.

The purpose of such checks is to verify certain information prior to the commencement of employment such as identity, right to work and educational qualifications. Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases.

Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories.

Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurology, infectious diseases and rare diseases.

Regeneron is also proud of award winning culture of innovation, being recognized as a Great Place to Work in 2021, Fast Company’s Best Workplace for Innovators in 2020, and Forbes JUST companies in 2020, among others.